The initiative aims to provide the Galleri multi-cancer early detection screening test to a select group of SBLI’s Bank-Owned Life Insurance (BOLI) policyholders.
The Galleri test will initially be available to chosen SBLI BOLI policyholders based on their significant impact on SBLI’s overall business, their size, and the underwriting process of the business. This pilot phase will allow SBLI to assess the impact and benefits for its customers, with potential plans to expand the Galleri test to more product lines in the future.
This collaboration represents a proactive approach by SBLI to enhance customer health outcomes through innovative early detection methods.
Jim Morgan, president and chief executive officer of SBLI, said: “Our partnership with GRAIL exemplifies SBLI’s ongoing focus on innovation within the insurance sector, both today and looking forward to the future. GRAIL’s groundbreaking work in early cancer detection aligns perfectly with our mission to foster the health and longevity of our customers. By offering this test, SBLI not only enhances its policy benefits but also affirms our dedication to the well-being of our policyholders.” –
Josh Ofman, MD, MSHS, president at GRAIL, added: “While doctors can screen for five specific cancers today, nearly 70% of cancer deaths are caused by cancers without recommended screening. We applaud SBLI’s leadership for their commitment to health and longevity by offering innovative cutting-edge screening technology and medical advancements like our first-of-its-kind Galleri test.”
Join GRAIL leaders at Insurtech Insights USA 2024 in New York on June 5th and 6th
The upcoming Insurtech Insights USA 2024 conference at the Javits Center in New York will feature a series of insightful speeches and live on-stage panel sessions with top speakers from GRAIL.
Presentation by Josh Ofman, President of GRAIL: “Using Multi-Cancer Early Detection (MCED) and Innovation to Make an Impact”
Josh Ofman, President of GRAIL, Inc., will kick off the day with a 15-minute presentation on the Tech Stage. His talk, “Using Multi-Cancer Early Detection (MCED) and Innovation to Make an Impact,” will explore the latest advancements in MCED technologies and their significant implications for the insurance industry. Attendees will gain insights into how innovative detection methods can transform risk assessment and policyholder health outcomes.
A main stage panel titled “Redefining What Life Insurance Can Do” will bring together industry leaders to discuss the evolving capabilities and roles of life insurance.
Panelists Sears Merritt, Head of Enterprise Technology & Experience at Mass Mutual, and Marc Miguere, President & CEO, US (Life and Health) at Munich Re will join Josh Ofman to share their perspectives on how life insurance products can be adapted to better meet the needs of modern consumers. Moderated by Insurtech Insights USA President, Megan Kuczynski, the session will provide valuable insights into innovative approaches within the sector.
Wendy Strait, VP of Enterprise Channels Growth at GRAIL, Inc. will take part in the panel session: “Building Life Insurance Products for the Next Generation”
This session will focus on how insurers can create life insurance products tailored to the unique needs and preferences of the next generation of consumers.
